Insider · CIK 0001761768
Martinez Maria E
Reports to the SEC for 2 companies · SEATTLE, WA
Transactions
31
Companies
2
Filings
7
CIK
0001761768
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-03-02 | CATXPerspective Therapeutics, Inc. · Stock option (right to buy)A Award | — |
| 2025-09-03 | CATXPerspective Therapeutics, Inc. · Stock option (right to buy)A Award | — |
| 2024-01-23 | Mirati Therapeutics, Inc.D Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.D Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.D Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer | — |
| 2023-12-29 | Mirati Therapeutics, Inc.A Award | +$400K |
| 2023-01-20 | Mirati Therapeutics, Inc.A Award | — |
| 2023-01-20 | Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)A Award | — |
| 2022-01-14 | Mirati Therapeutics, Inc.A Award | — |
| 2022-01-14 | Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)A Award | — |
| 2021-01-29 | Mirati Therapeutics, Inc.M Exercise/Conversion | +$298K |
| 2021-01-29 | Mirati Therapeutics, Inc.S Sale | −$9,857 |
| 2021-01-29 | Mirati Therapeutics, Inc.S Sale | −$49.6K |
| 2021-01-29 | Mirati Therapeutics, Inc.S Sale | −$144K |
| 2021-01-29 | Mirati Therapeutics, Inc.S Sale | −$92.8K |
| 2021-01-29 | Mirati Therapeutics, Inc.S Sale | −$194K |
| 2021-01-29 | Mirati Therapeutics, Inc.S Sale | −$321K |
| 2021-01-29 | Mirati Therapeutics, Inc.S Sale | −$246K |
| 2021-01-29 | Mirati Therapeutics, Inc.S Sale | −$200K |
| 2021-01-29 | Mirati Therapeutics, Inc.S Sale | −$227K |
| 2021-01-29 | Mirati Therapeutics, Inc.S Sale | −$41.6K |
| 2021-01-29 | Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)M Exercise/Conversion | — |
| 2021-01-15 | Mirati Therapeutics, Inc.A Award | — |
| 2021-01-15 | Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)A Award | — |
| 2020-01-03 | Mirati Therapeutics, Inc.A Award | — |
| 2020-01-03 | Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)A Award | — |
| 2019-01-17 | Mirati Therapeutics, Inc.Non-Qualified Stock Option (right to buy)A Award | — |
| 2018-12-06 | Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)A Award | — |
Recent filings
- 4Martinez Maria E0001761768-26-000003SEC(opens sec.gov)
- 4Martinez Maria E0000950170-25-113243SEC(opens sec.gov)
- 4Martinez Maria E0001140361-24-003539SEC(opens sec.gov)
- 4Martinez Maria E0001628280-24-000319SEC(opens sec.gov)
- 4Martinez Maria E0001214659-23-001039SEC(opens sec.gov)
- 4Martinez Maria E0001214659-22-000845SEC(opens sec.gov)
- 4Martinez Maria E0001214659-21-001095SEC(opens sec.gov)
Companies
Address
C/O PERSPECTIVE THERAPEUTICS, INC. 2401 ELLIOTT AVENUE, SUITE 320
SEATTLE, WA, 98121